Clinical drug development expert brings 35 years of experience to SciMar’s mission to accelerate life-changing drugs to market ALLENTOWN, NJ, July 14, 2023 – SciMar ONE, Inc. (SciMar) welcomes Marco Taglietti, MD, to its Board of Advisors. Marco is a 35-year pharmaceutical industry veteran whose career spans various clinical and executive roles with Fortune 500 and […]
Clinical Researcher: Closing Pharma’s Financial Chasm by Measuring and Improving Development Velocity
The top 14 R&D-focused pharma companies waste $2.8B annually during drug development, >60% could be saved by incorporating AI.
SciMar ONE helps pharma accelerate life-changing therapies to patients.
NJ Tech Weekly: Woman-led SciMar ONE is all-in on New Jersey as its drug development offering evolves
NJ Tech Weekly profiled SciMar ONE, a New Jersey tech company accelerating drug development.
SciMar CEO Donna Conroy was featured in a Fast Company article on the value of industry conferences to expand your professional network and promote professional growth. Read the original post here. If you want to strengthen your professional network, skills and knowledge, making time to attend industry conferences can be a great strategy As a […]
The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using the same antiquated, manual processes to move those life-changing therapies toward commercialization.
The program recognizes innovative New Jersey companies and individuals for excellence and leadership in digital technology fields. SciMar ONE is proud to be making a difference in the NJ technology community through our efforts to accelerate drug development.
SciMar ONE chosen for Merck Digital Sciences Studio. The collaboration is focused on improving Development Velocity™.
By Donna Conroy, MS, published in Clinical Researcher
Development Velocity is the speed a pharmaceutical company moves a therapy through the development process and into the market.
SciMar Named Semi-Finalist on Pepperdine Graziadio Business School’s Most Fundable Companies List 2022
SciMar ONE was named semi-finalist on Pepperdine Graziadio Business School’s Most Fundable Companies list.
SciMar ONE and CEO Donna Conroy were featured by MedCity News in a preview of the healthcare startups competing at HLTH 2022.